Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS